The Week in Review: February 9 – February 16, 2018

Friday, February 16, 2018 News Recap: HCV & Heart Disease: Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD. This article examines the evidence for clinical and subclinical cardiovascular diseases in chronic hepatitis c infection, as well as the effect of treatment on cardiovascular outcomes. News from Around the World: NZ: Thousands of Hepatitis C sufferers unaware a cure is within reach. A Hepatitis...

NZ: Thousands of Hepatitis C sufferers unaware a cure is within reach

A Hepatitis C survivor says she has been forced to do the government's work to ensure others with the potentially life-threatening virus get access to "miracle" drugs. Dunedin's Hazel Heal credits the drugs with saving her life and completely restoring her liver, but is angry the government is not informing people about the virus and treatment options. At least 50,000 Kiwis are estimated to have chronic Hepatitis C, but only half of them realise they h

The Week in Review: Dec 9 – Dec 16, 2016

Friday, December 16, 2016 News Recap Canada Lawyers representing the pre86/post90 group in the Canadian tainted blood compensation debacle issued a MEDIA ADVISORY on December 14, 2016 seeking more people to interview for special hearings in Toronto on December 15 – 16.  The hearings will also be broadcast in courtrooms in Edmonton, Vancouver, and Montreal (Hepatitis-C Tainted Blood Victims Fight Ottawa for Solution to $220M Fund Shortfall). Also in ...

NZ: Zepatier Now Approved in New Zealand

15 December 2016, Merck Sharp & Dohme (New Zealand) Ltd (MSD) today announced ZEPATIER® (elbasvir/grazoprevir) has been registered by Medsafe for the treatment of chronic Hepatitis C – genotype 1, 3* and 4 infection in adults. MSD New Zealand Director, Mr Paul Smith, adds, “Although ZEPATIER is now registered, it is not yet funded by PHARMAC. We will continue to work with PHARMAC in order to provide access to ZEPATIER for all appropriate G1, G3 and G4...

NZ: SDHB slated for hep C stand

This is a very interesting article about taking generics and how to get monitored and pay for it. In Canada, we are finding workarounds, but it is not easy!   (CD) A Dunedin Hospital staff member has criticised her employer, the Southern District Health Board, for refusing medical support for hepatitis C sufferers who are legally importing life-changing drugs. Tina Hill, an anaesthetic technician, cured herself of the disease a year ago by purchasing a

NZ: Hepatitis C drug funding could happen from July

A Pharmac proposal to fund hepatitis C drugs has created a stir among sufferers, but not everyone will be covered, Hepatitis C Resource Centre Otago co-ordinator Allison Beck says. This week the drug-buying agency announced a proposal to fund Harvoni and Viekira Pak, which are highly effective at curing hepatitis C. If approved, they could be available in July. They would be reserved for hepatitis C patients with severe liver disease for all but one la